What the work claims
That inoculation with cowpox material confers immunity to smallpox — verified by direct challenge with variolous material.
How it was done
Jenner inoculated James Phipps with cowpox pus from Sarah Nelmes’s hands on 14 May 1796. He then challenged Phipps with variolous material on 1 July 1796 and again later. He repeated this across 23 subjects, including his infant son. He showed cowpox material could be passed person-to-person.
What holds up
Phipps developed only mild symptoms after cowpox inoculation. He showed no disease after two separate challenges with variolous material. No unexpected side effects occurred. No breakthrough smallpox occurred in any recipient. Jenner demonstrated person-to-person transmission of protective cowpox material.
What does not
The sources do not establish that Jenner discovered cowpox inoculation, invented vaccination, or proved its safety for populations. They do not report sample size beyond 23, error rates, statistical analysis, or long-term follow-up beyond absence of breakthrough smallpox.
Why it matters beyond the lab
It established challenge as evidence of immunity — a conceptual pivot from empirical observation to experimental proof. That logic underpins modern vaccine regulation, though the trial design lacked controls, blinding, or quantification.
Is it worth your time
Yes. It is the first documented use of controlled challenge to verify immunity in humans — a method still foundational to vaccine evaluation.
